Rationale: MDMA alters body temperature in rats with a direction that depends on the ambient temperature (T). The thermoregulatory effects of MDMA and T may affect intravenous self-administration (IVSA) of MDMA but limited prior reports conflict.
Objective: To determine how body temperature responses under high and low T influence MDMA IVSA.
Methods: Male Sprague-Dawley rats were trained to IVSA MDMA (1.0mg/kg/infusion; 2-h sessions; FR5 schedule of reinforcement) under T 20°C or 30°C. Radiotelemetry transmitters recorded body temperature and activity during IVSA.
Results: MDMA intake increased under both T during acquisition, but to a greater extent in the 30°C group. The magnitude of hypothermia was initially equivalent between groups but diminished over training in the 30°C group. Within-session activity was initially lower in the 30°C group, but by the end of acquisition and maintenance, activity was similar for both groups. When T conditions were swapped, the hot-trained group increased MDMA IVSA under 20°C T and a modest decrease in drug intake was observed in the cold-trained group under 30°C T. Subsequent non-contingent MDMA (1.0-5.0mg/kg, i.v.) found that rats with higher MDMA IVSA rates showed blunted hypothermia compared with rats with lower IVSA levels; however, within-session activity did not differ by group. High T increased intracranial self-stimulation thresholds in a different group of rats and MDMA reduced thresholds below baseline at low, but not high, T.
Conclusions: High T appears to enhance acquisition of MDMA IVSA through an aversive effect and not via thermoregulatory motivation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688002 | PMC |
http://dx.doi.org/10.1016/j.pbb.2017.10.008 | DOI Listing |
Curr Top Behav Neurosci
December 2024
Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY, USA.
Humans have long used classical serotonergic psychedelics, such as psilocybin, for a variety of purposes. Entactogens, such as methylenedioxymethamphetamine (MDMA), emerged during the twentieth century and have likewise seen use in a broad range of settings. Interest has arisen in the use of classical psychedelics and entactogens, together termed "psychedelics," for therapeutic purposes in Western clinical settings.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S Maryland Ave, Chicago, IL, 60637, USA.
Psychoactive drugs such as alcohol and stimulants are typically used in social settings such as bars, parties or small groups. Yet, relatively little is known about how social contexts affect responses to drugs, or how the drugs alter social interactions. It is possible that positive social contexts enhance the rewarding properties of drugs, perhaps increasing their potential for repeated use and abuse.
View Article and Find Full Text PDFPsychopharmacology (Berl)
December 2024
Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, 800 E. Leigh St., STE 205, Richmond, VA, 23219-0540, USA.
Rationale α-ET (α-ethyltryptamine), a homolog of the classical hallucinogen α-methyltryptamine, was once prescribed clinically as an antidepressant. Classical psychedelic drugs are currently of interest as potential pharmacotherapy for psychiatric disorders. Objectives Drug discrimination was used to (a) determine if α-ET-like stimulus effects could be engendered by the prototypical phenylalkylamines MDMA ("Ecstasy") or MDA ("Love Drug") and (b) evaluate the α-ET-like stimulus effects of four synthesized aryl-substituted monomethoxy analogs of α-ET (4-OMe-, 5-OMe-, 6-OMe- and 7-OMe-α-ET).
View Article and Find Full Text PDFJ Psychopharmacol
December 2024
Department of Psychology, University of Exeter, Exeter, UK.
The recent rejection of 3,4-methylenedioxymethamphetamine (MDMA)-assisted therapy by the U.S. Food and Drug Administration (FDA) is a dramatic moment in the re-emergence of psychedelic research.
View Article and Find Full Text PDFFront Hum Neurosci
December 2024
Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!